U.S. markets closed

IRadimed Corporation (IRMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
22.14+0.46 (+2.12%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 8/11/2020
Current
6/30/20203/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
266.28M283.11M255.58M275.09M240.29M228.17M
Enterprise Value 3
221.33M238.59M212.29M235.54M205.56M195.86M
Trailing P/E
50.5830.1427.3735.4231.8534.08
Forward P/E 1
60.2445.4523.9825.7120.8329.24
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
7.287.376.807.967.667.85
Price/Book (mrq)
4.564.884.605.315.105.13
Enterprise Value/Revenue 3
6.0935.1124.4621.6320.6321.23
Enterprise Value/EBITDA 6
58.18-91.59196.1993.4873.2173.59

Trading Information

Stock Price History

Beta (5Y Monthly) 1.31
52-Week Change 33.34%
S&P500 52-Week Change 317.36%
52 Week High 328.43
52 Week Low 314.41
50-Day Moving Average 323.27
200-Day Moving Average 322.46

Share Statistics

Avg Vol (3 month) 352.13k
Avg Vol (10 day) 366.41k
Shares Outstanding 512.24M
Float 5.53M
% Held by Insiders 150.52%
% Held by Institutions 133.19%
Shares Short (Jul 30, 2020) 4389.26k
Short Ratio (Jul 30, 2020) 48.62
Short % of Float (Jul 30, 2020) 46.22%
Short % of Shares Outstanding (Jul 30, 2020) 43.19%
Shares Short (prior month Jun 29, 2020) 4435.05k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 14.74%
Operating Margin (ttm)15.87%

Management Effectiveness

Return on Assets (ttm)5.74%
Return on Equity (ttm)10.15%

Income Statement

Revenue (ttm)36.33M
Revenue Per Share (ttm)3.10
Quarterly Revenue Growth (yoy)-26.30%
Gross Profit (ttm)29.7M
EBITDA 7M
Net Income Avi to Common (ttm)5.35M
Diluted EPS (ttm)0.44
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.78M
Total Cash Per Share (mrq)3.9
Total Debt (mrq)2.84M
Total Debt/Equity (mrq)4.86
Current Ratio (mrq)11.44
Book Value Per Share (mrq)4.78

Cash Flow Statement

Operating Cash Flow (ttm)9.07M
Levered Free Cash Flow (ttm)8.57M